Is BioAtla, Inc. (BCAB) a Buy, Sell, or Hold?
NASDAQ : BCAB
BioAtla, Inc. — Institutional Ownership
$3.46 USD
$0.13 (3.9%)
- Volume
- 36.74K
- Average Volume
- 48.92K
- Market Capitalization
- $5.74M
- P/E Ratio
- -0.08
- Dividend Yield
- 0.00%
- Price Target
- $250.00
- Year High
- $71.50
- Year Low
- $3.12
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.15
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2025-10-15 | OPOKA INVESTMENT FUND Co | 2.81M | 4.80% |
| 2025-05-20 | ACORN BIOVENTURES, L.P. | 2.16M | 3.70% |
| 2025-04-25 | Highbridge Capital Management, LLC | 4.84M | 7.70% |
| 2025-03-18 | OPOKA INVESTMENT FUND Co | 3.55M | 6.10% |
| 2025-02-10 | Highbridge Capital Management, LLC | 7.35M | 9.90% |
| 2025-02-07 | Jay M. Short | 3.87M | 6.60% |
| 2025-01-24 | Millennium Management LLC | 1.1M | 1.90% |
| 2024-08-07 | Millennium Management LLC | 2.41M | 5.00% |
| 2024-08-07 | Millennium Group Management LLC | 2.41M | 5.00% |
| 2024-08-07 | Israel A. Englander | 2.41M | 5.00% |
| 2024-01-29 | (1) BlackRock, Inc. | 2.88M | 6.00% |
| 2023-04-27 | Acorn Bioventures, L.P. | 1.31M | 2.80% |
| 2023-04-27 | Acorn Capital Advisors GP 2, LLC | 1.41M | 3.00% |
| 2023-04-27 | Acorn Capital Advisors GP, LLC | 1.31M | 2.80% |
| 2023-04-27 | Anders Hove | 2.73M | 5.70% |
| 2023-04-27 | Acorn Bioventures 2 L.P. | 1.41M | 3.00% |
| 2022-02-09 | The Vanguard Group - 23-1945930 | 2.26M | 6.41% |
| 2022-02-04 | Wellington Investment Advisors Holdings LLP | 3.23M | 9.15% |
| 2022-02-04 | Wellington Group Holdings LLP | 3.23M | 9.15% |
| 2022-02-04 | Wellington Management Group LLP | 3.23M | 9.15% |
| 2022-02-04 | Wellington Management Company LLP | 3.01M | 8.51% |
| 2021-02-16 | Pfizer Ventures (US) LLC | 2.24M | 7.00% |
| 2021-02-16 | Pfizer Inc. | 2.24M | 7.00% |
| 2021-02-08 | FMR LLC | 1.78M | 5.53% |
| 2021-02-08 | Abigail P. Johnson | 1.78M | 5.53% |
| 2020-12-28 | SOLEUS CAPITAL, LLC | 1.06M | 3.28% |
| 2020-12-28 | SOLEUS CAPITAL GROUP, LLC | 1.06M | 3.28% |
| 2020-12-28 | SOLEUS BA SPV, LLC | 333.33K | 1.04% |
| 2020-12-28 | GUY LEVY | 3.19M | 9.93% |
| 2020-12-28 | Cormorant Global Healthcare Master Fund, LP | 1.08M | 3.34% |
| 2020-12-28 | Cormorant Global Healthcare GP, LLC | 1.08M | 3.34% |
| 2020-12-28 | Cormorant Private Healthcare Fund II, LP | 1.18M | 3.67% |
| 2020-12-28 | Cormorant Private Healthcare GP II, LLC | 1.18M | 3.67% |
| 2020-12-28 | Cormorant Asset Management, LP | 2.29M | 7.12% |
| 2020-12-28 | Bihua Chen | 2.29M | 7.12% |
| 2020-12-28 | SOLEUS PRIVATE EQUITY FUND I, L.P. | 1.79M | 5.57% |
| 2020-12-28 | SOLEUS PRIVATE EQUITY GP I, LLC | 2.12M | 6.60% |
| 2020-12-28 | SOLEUS PE GP I, LLC | 2.12M | 6.60% |
| 2020-12-28 | Farallon Capital Management, L.L.C. | 1.73M | 5.40% |
| 2020-12-28 | SOLEUS CAPITAL MASTER FUND, L.P. | 1.06M | 3.28% |
| 2020-12-28 | Michael G. Linn | 1.97M | 6.10% |
| 2020-12-28 | Farallon Capital (AM) Investors, L.P. | 4400.0 | 0.00% |
| 2020-12-28 | Philip D. Dreyfuss | 1.97M | 6.10% |
| 2020-12-28 | Richard B. Fried | 1.97M | 6.10% |
| 2020-12-28 | David T. Kim | 1.97M | 6.10% |
| 2020-12-28 | Andrew J. M. Spokes | 1.97M | 6.10% |
| 2020-12-28 | John R. Warren | 1.97M | 6.10% |
| 2020-12-28 | Zone II Healthcare Holdings, LLC | 1.73M | 5.40% |
| 2020-12-28 | Farallon Capital Institutional Partners, L.P. | 54000.0 | 0.20% |
| 2020-12-28 | Farallon Capital Institutional Partners II, L.P. | 10700.0 | 0.00% |
| 2020-12-28 | Farallon Capital Institutional Partners III, L.P. | 6200.0 | 0.00% |
| 2020-12-28 | Four Crossings Institutional Partners V, L.P. | 8200.0 | 0.00% |
| 2020-12-28 | Michael B. Fisch | 1.97M | 6.10% |
| 2020-12-28 | Rajiv A. Patel | 1.97M | 6.10% |
| 2020-12-28 | Thomas G. Roberts, Jr. | 1.97M | 6.10% |
| 2020-12-28 | William Seybold | 1.97M | 6.10% |
| 2020-12-28 | Mark C. Wehrly | 1.97M | 6.10% |
| 2020-12-28 | HBM Healthcare Investments (Cayman) Ltd. | 2.69M | 8.80% |
| 2020-12-28 | Farallon Capital Offshore Investors II, L.P. | 109.4K | 0.30% |
| 2020-12-28 | Farallon Capital F5 Master I, L.P. | 11200.0 | 0.00% |
| 2020-12-28 | Farallon Capital Partners, L.P. | 33400.0 | 0.10% |
| 2020-12-28 | Farallon Partners, L.L.C. | 226.3K | 0.70% |
| 2020-12-28 | Farallon Institutional (GP) V, L.L.C. | 8200.0 | 0.00% |
| 2020-12-28 | Farallon F5 (GP), L.L.C. | 11200.0 | 0.00% |
BCAB Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $28.39 | 1.18M | $33.4M | $7.12M | $6.2M | $32.48M |
| 2024-12-31 | $29.56 | 971.47K | $28.72M | $49.05M | $836K | -$19.49M |
| 2023-12-31 | $123.00 | 955.55K | $117.53M | $111.47M | $2.46M | $8.52M |
| 2022-12-31 | $412.50 | 778.54K | $321.15M | $215.51M | $3.98M | $109.62M |
| 2021-12-31 | $981.50 | 691.22K | $678.44M | $244.98M | $5.37M | $438.83M |
| 2020-12-31 | $1700.50 | 673.27K | $1.14B | $238.6M | $682K | $906.98M |
| 2019-12-31 | $1551.00 | 673.27K | $1.04B | $3.7M | $18.12M | $1.06B |
| 2018-12-31 | $1551.00 | 431.77K | $669.68M | $10.86M | $15M | $673.82M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8.05 | 1.5M | $12.09M | $1.96M | $6.09M | $16.22M |
| 2025-12-31 | $28.39 | 1.18M | $33.4M | $7.12M | $6.2M | $32.48M |
| 2025-09-30 | $34.39 | 1.17M | $40.41M | $8.32M | $6.18M | $38.27M |
| 2025-06-30 | $19.80 | 1.17M | $23.17M | $18.21M | $6.04M | $11.01M |
| 2025-03-31 | $17.34 | 1.16M | $20.2M | $32.36M | $554K | -$11.61M |
| 2024-12-31 | $29.56 | 998.99K | $29.53M | $49.05M | $836K | -$18.68M |
| 2024-09-30 | $88.00 | 966.72K | $85.07M | $56.52M | $1.25M | $29.81M |
| 2024-06-30 | $67.50 | 964.3K | $65.09M | $61.66M | $1.66M | $5.09M |
| 2024-03-31 | $169.50 | 961.75K | $163.02M | $80.63M | $1.92M | $84.31M |
| 2023-12-31 | $123.00 | 960.63K | $118.16M | $111.47M | $2.46M | $9.15M |
| 2023-09-30 | $85.00 | 956.68K | $81.32M | $141.28M | $2.85M | -$57.12M |
| 2023-06-30 | $150.00 | 954.13K | $143.12M | $168.69M | $3.23M | -$22.34M |